Sol-Gel Technologies Ltd. (SLGL)
NASDAQ: SLGL · Real-Time Price · USD
74.40
+1.73 (2.38%)
Jun 26, 2026, 2:36 PM EDT - Market open
Sol-Gel Technologies Market Cap
Sol-Gel Technologies has a market cap or net worth of $243.21 million as of June 26, 2026. Its market cap has increased by 1,160.17% in one year.
Market Cap
243.21M
Enterprise Value
185.59M
1-Year Change
1,160.17%
Ranking
Category
Stock Price
$74.40
Market Cap Chart
Since February 1, 2018, Sol-Gel Technologies's market cap has increased from $228.30M to $243.21M, an increase of 6.53%. That is a compound annual growth rate of 0.76%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jun 26, 2026 | 243.21M | 107.17% |
| Dec 31, 2025 | 117.40M | 353.28% |
| Dec 31, 2024 | 25.90M | -15.91% |
| Dec 29, 2023 | 30.80M | -70.81% |
| Dec 30, 2022 | 105.50M | -38.34% |
| Dec 31, 2021 | 171.10M | -24.02% |
| Dec 31, 2020 | 225.20M | -35.58% |
| Dec 31, 2019 | 349.60M | 206.94% |
| Dec 31, 2018 | 113.90M | -50.11% |
| Feb 1, 2018 | 228.30M | - |
View and export this data all the way back to 2018. Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| AC Immune | 243.04M |
| Cybin | 242.67M |
| Orchestra BioMed Holdings | 241.92M |
| Anavex Life Sciences | 239.09M |
| ALX Oncology Holdings | 236.83M |
| Whitehawk Therapeutics | 235.03M |
| Camp4 Therapeutics | 226.40M |
| Canton Strategic Holdings | 225.47M |